YA II PN, Ltd. - Mar 24, 2025 SCHEDULE 13G Report for Scinai Immunotherapeutics Ltd. American Depository Shares, each representing 4,000 Ordinary Shares, no par value

Filing Manager
YA II PN, Ltd.
Reporting Manager
YA II PN, Ltd.
Security
Scinai Immunotherapeutics Ltd. American Depository Shares, each representing 4,000 Ordinary Shares, no par value
Shares outstanding
942K shares
Disclosed Ownership
93.3K shares
Ownership
9.9%
Form type
SCHEDULE 13G
Date filed
3/26/2025, 06:22 PM
Date of event
Mar 24, 2025
SEC
View on sec.gov

Reporting Managers (8)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
YA II PN, Ltd. 9.9% 93.3K 0 93.3K /s/ David Gonzalez David Gonzalez, General Counsel
YA Global Investments II (U.S.), LP 9.9% 93.3K 0 93.3K /s/ David Gonzalez David Gonzalez, General Counsel
Yorkville Advisors Global, LP 9.9% 93.3K 0 93.3K /s/ David Gonzalez David Gonzalez, General Counsel
Yorkville Advisors Global II, LLC 9.9% 93.3K 0 93.3K /s/ David Gonzalez David Gonzalez, General Counsel
YAII GP, LP 9.9% 93.3K 0 93.3K /s/ David Gonzalez David Gonzalez, General Counsel
YAII GP II, LLC 9.9% 93.3K 0 93.3K /s/ David Gonzalez David Gonzalez, General Counsel
Mark Angelo 9.9% 93.3K 0 93.3K /s/ Mark Angelo Mark Angelo
SC-Sigma Global Partners, LP 9.9% 93.3K 0 93.3K /s/ David Gonzalez David Gonzalez, General Counsel